Veterinary Medicines

FILARIVE, 142,8 µg, 116,3 mg, 335,2 mg, compresse masticabili per cani

Authorised
  • Ivermectin
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
FILARIVE, 142,8 µg, 116,3 mg, 335,2 mg, compresse masticabili per cani
Active substance:
  • Ivermectin
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ivermectin
    142.80
    microgram(s)
    /
    1.00
    Tablet
  • Praziquantel
    116.30
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    335.20
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac S.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104199
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 1/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."